Presentation to feature complete safety and immunogenicity dataset from the Phase 1 clinical study of VBI-1501 Oral presentation at IDWeek 2018 on Saturday, October 6 th, 2018, at 11:10 AM PDT ...
BERKELEY HEIGHTS, N.J., Oct. 11, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention ...
BEDMINSTER, N.J., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on improving the intracellular delivery of ...
Please provide your email address to receive an email when new articles are posted on . LOS ANGELES — David J. Weber, MD, MPH, weighed in on findings from the Society of Healthcare Epidemiology of ...
In anticipation of IDWeek every year, each of the four sponsoring societies selects one abstract as its top submission from international investigators. Drs. Atukunda and Boulware will present the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results